Advertisement

Topics

Cutera Company Profile

09:38 EDT 25th September 2017 | BioPortfolio

Cutera was founded in 1998 with a goal of becoming the worldwide leading provider of laser and other light-based aesthetic systems to the aesthetic market. With our easy-to-use products, dermatologists, plastic surgeons, gynecologists, primary care physicians and other qualified practitioners can offer safe, effective and non-invasive aesthetic treatments to their patients. We commercially launched our first product, the CoolGlide® CV, in March of 2000 for hair removal, and every year since we have introduced at least one new product for our customers to treat additional aesthetic conditions. A key feature of our products is their upgradeable design; each time we introduced a new product, customers have been able to increase the capability of their earlier-generation systems by upgrading to the newest system for an incremental cost. This has provided our customers a cost-effective way to add new services to their patients. Our comprehensive product family is available on your choice of three platforms: Xeo – high performance, multi-application technology Solera – compact flash lamp or infrared technology CoolGlide – high performance laser-based technology Current applications of our product family include: permanent hair reduction on all skin types and tanned skin; treatment of vascular conditions, including leg and facial veins; a wide range of non-ablative skin rejuvenation applications; and the treatment of pigmented lesions.

Location

3240 Bayshore Boulevard
Brisbane
CA
94005
United States of America

Contact

Phone: (888) 4-CUTERA or (415) 657-5500
Fax: (415) 330-2444
Email: service@cutera.com


News Articles [11 Associated News Articles listed on BioPortfolio]

Cutera (CUTR) Investor Presentation - Slideshow

Cutera Announces Retirement Of As Member Of The Board Of Directors

  Life Sciences Jobs   ...

Cutera Strengthens Leadership Team With Two Key Executive Appointments

  Life Sciences Jobs   ...

Cutera To Host Analyst & Investor Day On June 14, 2017

  Life Sciences Jobs   ...

Cutera's (CUTR) CEO James Reinstein on Q2 2017 Results - Earnings Call Transcript

Cutera Reports Second Quarter 2017 Financial Performance, Increases Revenue And EPS Guidance And Expands Stock Buyback Program

  Life Sciences Jobs   ...

IRIDEX and Cutera Close Acquisition of IRIDEX' Aesthetic Business Unit

MOUNTAIN VIEW, Calif., Feb. 3, 2012  /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that IRIDEX and Cutera, Inc. (NASDAQ: CUTR) have closed their previously announced purchase ...

Cutera Inc CUTR Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryCutera Inc Cutera is a medical device company that designs, manufactures and markets aesthetic devices. The company provides products that include enlighten, excel V, excel HR, truSculpt, and x...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Pivotal Study of the Cutera truSculpt Radiofrequency Device for Wrinkle Reduction

The purpose of this pivotal investigation is to evaluate the safety and efficacy of the Cutera truSculpt™ radiofrequency (RF) Device for Wrinkle Reduction.

Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal

Study to evaluate safety and efficacy of treatment with the investigational Cutera enlighten laser for tattoo removal as compared to treatment with the Cynosure PicoSure laser

Radio Frequency Device for Reduction in Size of Localized Areas of the Body

The purpose of this study is to evaluate the Cutera radio frequency device for the new indication of reduction in size of localized areas of the body.

Multi-Wavelength Laser Tattoo Removal Pivotal Study

Mult-center study to evaluate the safety and efficacy of an investigational version of the Cutera enlighten laser that offers multiple wavelengths for tattoo removal

Chart Review of the Efficacy of the GenesisPlus 1064 nm Nd:YAG Laser in the Treatment of Onychomycosis

The purpose of this study is to determine if toenail onychomycosis can be reduced by means of exposure to laser energy from the Cutera® GenesisPlus 1064 Nd:YAG laser system.

Companies [2 Associated Companies listed on BioPortfolio]

Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other light-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use pro...

Cutera

Cutera was founded in 1998 with a goal of becoming the worldwide leading provider of laser and other light-based aesthetic systems to the aesthetic market. With our easy-to-use products, dermatologist...

More Information about "Cutera" on BioPortfolio

We have published hundreds of Cutera news stories on BioPortfolio along with dozens of Cutera Clinical Trials and PubMed Articles about Cutera for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cutera Companies in our database. You can also find out about relevant Cutera Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...


Corporate Database Quicklinks



Searches Linking to this Company Record